Janux Therapeutics, Inc. (JANX)

NASDAQ: JANX · Real-Time Price · USD

25.70

+0.16 (0.63%)

May 7, 2025, 4:00 PM EDT - Market closed

Janux Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	May '25 May 7, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	1,521	3,087	495	547	821	-	Upgrade
Market Cap Growth	523.34%	523.34%	-9.51%	-33.35%	-	-	Upgrade
Enterprise Value	518	2,452	170	233	434	-	Upgrade
Last Close Price	25.70	53.54	10.73	13.17	19.73	-	Upgrade
PS Ratio	130.47	291.54	61.27	63.54	225.73	-	Upgrade
PB Ratio	1.48	3.02	1.44	1.71	2.24	-	Upgrade
P/TBV Ratio	1.49	3.02	1.44	1.71	2.24	-	Upgrade
EV/Sales Ratio	48.97	231.60	21.08	27.00	119.25	-	Upgrade
Debt / Equity Ratio	0.02	0.02	0.07	0.08	0.00	-	Upgrade
Asset Turnover	0.02	0.02	0.02	0.02	0.02	-	Upgrade
Quick Ratio	59.03	59.03	26.56	19.85	29.32	4.97	Upgrade
Current Ratio	59.21	59.21	26.80	20.14	29.46	5.05	Upgrade
Return on Equity (ROE)	-10.09%	-10.09%	-17.53%	-18.36%	-17.50%	-446.61%	Upgrade
Return on Assets (ROA)	-8.57%	-8.57%	-12.25%	-11.27%	-10.39%	-35.83%	Upgrade
Return on Capital (ROIC)	-8.73%	-8.73%	-12.76%	-11.77%	-11.02%	-86.02%	Upgrade
Earnings Yield	-4.54%	-2.23%	-11.77%	-11.52%	-3.98%	-	Upgrade
FCF Yield	-2.90%	-1.43%	-10.59%	-9.02%	-2.25%	-	Upgrade
Buyback Yield / Dilution	-22.12%	-22.12%	-6.14%	-76.24%	-2471.20%	-36.71%	Upgrade

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q